DIVIDEND WITHHOLDING TAX UNDER THE CHINA-Israel TREATY (INDICATIVE)
10% — verify against the current DTA text and substance requirements before structuring.
Key points for investors from Israel
- R&D WFOE structure captures super-deduction incentives
- Medtech: NMPA registration + pilot hospital partnerships
- Dual-use tech: pre-screen export-control overlap both directions
Israeli entrants bring deep-tech: semiconductors, medtech, agritech and cybersecurity. China-Israel DTA: 10% dividends (verify). R&D centers qualify for the 100% super-deduction on qualifying R&D spend.
Where we come in
Zhonghui Consulting has delivered numerous cross-border compliance engagements: WFOE registration, tax structuring, work permits, data compliance and exit planning — fixed fees, English-speaking delivery, ICPA-licensed review.
Start your China entry the compliant way
Free 30-minute diagnosis · fixed-fee packages · English delivery team.
Start with a Free Diagnosis →General information only — not legal, tax, or investment advice. Tax-treaty rates shown are indicative; always verify against the current double-tax-arrangement text and official sources (SAMR, STA, SAFE, MOFCOM, NDRC) with licensed advisors.